Fundamental Analysis of Thorne HealthTech Inc - Growth / Value Index
THRN - Valuation Highlights
Valuation Analysis
Undervalued - Price to Intrinsic Value of 0
Tsr Value Index - Very Poor Score of 9.38
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -0.0013 | 34.30 | -32.97 % | |
| Price to Book | -0.0000 | 3.67 | 16.87 % | 3.54 |
| Price to Sales | 0 | 2.35 | 17.30 % | |
| Enterprise Value to EBITDA Multiple | -0.0362 | 22.54 | -12.76 % |
THRN - Profitability Highlights
Profitability Analysis
Company Earning excess return
EBITDA is continuously increasing for last 3 Years
Very Low Dividend Yield of 0 %
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | -1.36 | 10.81 | 76.66 % | 2.89 |
| Return On Asset | -177346.34 | 6.82 | 64.84 % | 1.57 |
| Net Profit Margin | -0.616 | 6.85 | 75.01 % | 6.11 |
| Operating Profit Margin | -1.18 | 2.40 | -54.48 % | 9.11 |
| EBITDA Margin | -0.0225 | 10.06 | 48.31 % | 11.76 |
Highlights
| Market Cap | 550634 K |
| Enterprise Value | 531759 K |
| Price/Book TTM | -0.0000 |
| Outstanding Share | 54036.80 K |
| Float/ Outstanding Share | 29.11% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | -36471.21 |
| Piotroski F Score | 3.00 |
| Altman Z Score | 4.91 |
| Sloan Ratio | 0.0455 |
| Peter Lynch Fair Value | 0 |
THRN - Growth Highlights
Growth Analysis
YoY Net Margin Jump by 75.01%
Steady increase in Total Assets for last 3 Years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 65237.97 B | 23.47 % | 100.00 % |
| Gross Profit | 34273.69 B | 18.06 % | 100.00 % |
| EBITDA | -14695.08 M | 83.13 % | 100.06 % |
| Net Profit | -402143.27 M | 116.09 % | 100.00 % |
| EPS | -7554.11 | 49.20 % | NA |
THRN - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 76.56
Altman Z Score of 4.91 suggests good Stability
Company is unable to generate enough free cash to support the business.
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0.118 | 203.16 % | 0.190 |
| Cash Ratio | 0.911 | -54.14 % | |
| Quick Ratio | 1.47 | -37.40 % | 1.13 |
| Shareholders Equity | 63.09 | -6.69 % | |
| Debt to EBITDA | 0.745 | 102.50 % |
Historical Valuation Ratios of Thorne HealthTech Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Thorne HealthTech Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Thorne HealthTech Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Thorne HealthTech Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)